1.31
+0(+0.00%)
Currency In USD
| Previous Close | 1.31 |
| Open | 1.32 |
| Day High | 1.35 |
| Day Low | 1.28 |
| 52-Week High | 1.83 |
| 52-Week Low | 0.28 |
| Volume | 1.1M |
| Average Volume | 2.39M |
| Market Cap | 518.06M |
| PE | -6.89 |
| EPS | -0.19 |
| Moving Average 50 Days | 1.3 |
| Moving Average 200 Days | 1.15 |
| Change | 0 |
If you invested $1000 in Lexicon Pharmaceuticals, Inc. (LXRX) 10 years ago, it would be worth $138.92 as of February 15, 2026 at a share price of $1.31. Whereas If you bought $1000 worth of Lexicon Pharmaceuticals, Inc. (LXRX) shares 5 years ago, it would be worth $166.45 as of February 15, 2026 at a share price of $1.31.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement
GlobeNewswire Inc.
Feb 06, 2026 10:17 PM GMT
THE WOODLANDS, Texas, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) today announced the closing of its previously announced underwritten public offering of 32,000,000 shares of its common stock, par valu
Lexicon Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private Placement
GlobeNewswire Inc.
Jan 30, 2026 7:50 AM GMT
THE WOODLANDS, Texas, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) today announced the pricing of its previously announced underwritten public offering of 32,000,000 shares of its common stock, par valu
Lexicon Announces Proposed Public Offering of Common Stock
GlobeNewswire Inc.
Jan 29, 2026 9:31 PM GMT
THE WOODLANDS, Texas, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) today announced that it has commenced an underwritten public offering to offer and sell, subject to market and other conditions, shares